Provider 1033144464
NPI: 1033144464Share
Active Billing Period:2018-01→2024-10(67 months)
Extreme procedure concentration — 69% of $8.8M billed through just 2 codes
Total Paid
$8.8M
$8,784,281
Total Claims
26K
Beneficiaries
1,719
14.9 claims/patient
Avg Cost/Claim
$343
Monthly Spending Trend
Yearly Spending
2018
$165K
+249%
2019
$576K
+9%
2020
$626K
+67%
2021
$1.0M
+7%
2022
$1.1M
+120%
2023
$2.5M
+13%
2024
$2.8M
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 2 distinct procedure codes. The top code (Q5001 (Injection, filgrastim-sndz, biosimilar, 1 mcg)) accounts for 69% of total spending.
ProcedureTotalYour Cost/ClaimNational Medianvs MedianPercentile
$6.1M
22K claims
$276.02
$23.43
11.8×
Top 25%
Q5001Top 25%
Injection, filgrastim-sndz, biosimilar, 1 mcg
$6.1M
22K claims · 69.2%
Your Cost: $276.02/claim|Median: $23.43
11.8× median$2.7M
3,594 claims
$754.00
$4,158.95
0.2×
Normal range
0658Normal range
Revenue code, pharmacy, generic drugs
$2.7M
3,594 claims · 30.8%
Your Cost: $754.00/claim|Median: $4,158.95
0.2× median